Juan Pablo Preciado Jimenez
Universidad de Guadalajara, Mexico
Title: Systemic Hypertension and Type 2 Diabetes Mellitus and lapse of diagnosis for End-Stage Kidney Disease in 18 patients from a Hospital of Puerto Vallarta, Jalisco. México.
Biography
Biography: Juan Pablo Preciado Jimenez
Abstract
Background: End-Stage Kidney Disease is directly related to hypertension, diabetes and dyslipidemia, which is today diseases that have reached epidemic proportions in our country. Methods: We conducted an analytical, observational, cross-sectional, retrospective study based on individuals, involving 18 patients assigned to the ISSSTE Hospital located in Puerto Vallarta, Jalisco. México, diagnosed with End-Stage Kidney Disease, in which we seek to establish an approximate time frame for the diagnosis of End-Stage Kidney Disease in patients with a previous diagnosis of Systemic Hypertension, Diabetes Mellitus Type 2 and both associated. Statistical analysis was performed using the Excel Analysis ToolPak for Microsoft Office Excel 2013. Results: Data were collected from 18 patients diagnosed with End Stage Kidney Disease, of which only 15 patient's (83.33%) were analyzed, otherwise 3 patient's (16.66%) were excluded, 2 of them by presenting a diagnosis of ESKD simultaneously to Type 2 Diabetes or Systemic Hypertension, and the remaining patient did not present any comorbidity when establishing the diagnosis of ESKD. Of the selected patients it was found that the category who took a shorter time to have as diagnosed ESKD were patients with Hypertension as unique comorbidity, with an average of 5.6 years, while the category of type 2 diabetes mellitus and associated hypertension, had an average of 9 years, and finally patients with type 2 diabetes mellitus only, showed an average of 20 years of evolution before they make a diagnosis of ESRD. Conclusions/Discussion: The results show a direct causal link between type 2 diabetes mellitus and hypertension, with the onset of chronic kidney failure, this time depending on the evolution of the disease. Being patients with hypertension as the only comorbidity those with the shortest period to develop terminal chronic renal impairment compared to patients with diabetes mellitus as one comorbidity, who show a slow and progressive deterioration, perhaps associated with various factors, a major by inhibiting the renin-angiotensin system, which slows the progression of kidney disease.